Featured News Recent October 20, 2026 Sinopia Biosciences Secures $2.5 Million NIH Grant to Advance Metabolomics Foundation Model for Drug Discovery October 20, 2026 Read more → October 20, 2026 October 1, 2026 In The News: Nature Reviews Drug Discovery Highlights Sinopia’s Recent Publication in Science Translational Medicine October 1, 2026 Read more → October 1, 2026 August 11, 2026 In The News: NIH Features Sinopia’s Science Translational Medicine Publication in Weekly Newsletter “Research Matters” August 11, 2026 Read more → August 11, 2026 July 15, 2026 Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease July 15, 2026 Read more → July 15, 2026 July 9, 2026 In The News: San Diego Business Journal Covers Sinopia’s Seed Financing and Lead Program in Parkinson’s disease July 9, 2026 Read more → July 9, 2026 March 3, 2026 Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders March 3, 2026 Read more → March 3, 2026 January 27, 2026 Sinopia Biosciences Strengthens Intellectual Property Estate with Issuance of Composition of Matter Patent January 27, 2026 Read more → January 27, 2026 April 1, 2025 In The News: Sinopia Biosciences selected as 2025 Cool Company by CONNECT April 1, 2025 Read more → April 1, 2025 All News
